BR0107421A - Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina - Google Patents

Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina

Info

Publication number
BR0107421A
BR0107421A BR0107421-0A BR0107421A BR0107421A BR 0107421 A BR0107421 A BR 0107421A BR 0107421 A BR0107421 A BR 0107421A BR 0107421 A BR0107421 A BR 0107421A
Authority
BR
Brazil
Prior art keywords
polypeptide
recombinant polypeptide
preparing
aqueous solvent
vaccine
Prior art date
Application number
BR0107421-0A
Other languages
English (en)
Inventor
Thierry Baussant
Pascale Jeannin
Yves Delneste
Francois Lawny
Jean-Yves Bonnefoy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR0107421A publication Critical patent/BR0107421A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Abstract

"PROCESSOS DE PREPARAçãO DE UMA SOLUçãO PURIFICADA DE POLIPEPTìDEO SOLúVEL EM SOLVENTE AQUOSO E DE MODULAçãO DO SISTEMA IMUNOLóGICO DE UM MAMìFERO, POLIPEPTìDEO RECOMBINANTE, UTILIZAçãO DE UM POLIPEPTìDEO RECOMBINANTE, COMPOSIçãO TERAPêUTICA E VACINA". A presente invenção refere-se a um novo processo de preparação de um polipeptídeo solúvel em solvente aquoso em ausência de detergente, assim como aos polipeptídeos susceptíveis de serem obtidos pelo processo de acordo com a invenção. A invenção refere-se também à utilização de tais polipeptídeos, particularmente para a preparação de medicamentos ou vacinas, destinados a combater particularmente as infecções bacterianas, virais ou os cânceres.
BR0107421-0A 2000-01-04 2001-01-04 Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina BR0107421A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000070A FR2803302B1 (fr) 2000-01-04 2000-01-04 Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent
PCT/FR2001/000023 WO2001049705A2 (fr) 2000-01-04 2001-01-04 Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent

Publications (1)

Publication Number Publication Date
BR0107421A true BR0107421A (pt) 2002-10-22

Family

ID=8845624

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107421-0A BR0107421A (pt) 2000-01-04 2001-01-04 Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina

Country Status (13)

Country Link
US (1) US7125696B2 (pt)
EP (1) EP1244690B1 (pt)
JP (1) JP2003519238A (pt)
CN (1) CN1258537C (pt)
AT (1) ATE364622T1 (pt)
AU (1) AU783851B2 (pt)
BR (1) BR0107421A (pt)
CA (1) CA2397714A1 (pt)
DE (1) DE60128891D1 (pt)
FR (1) FR2803302B1 (pt)
MX (1) MXPA02006650A (pt)
WO (1) WO2001049705A2 (pt)
ZA (1) ZA200204930B (pt)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3809796A1 (de) * 1988-03-23 1989-10-05 Wolfgang Prof Dr Med Bredt Verfahren zum reinigen eines 168 kd-proteins von mycoplasma pneumoniae
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US5534205A (en) * 1994-08-05 1996-07-09 The Dow Chemical Company Method for preparing polybenzoxazole or polybenzothiazole fibers
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
KR0158435B1 (ko) * 1996-01-30 1998-11-16 허영섭 헬리코박터 파이로리의 외막단백질 유전자 및 그를 발현하는 재조합 미생물
CN1087695C (zh) 1997-01-23 2002-07-17 大赛璐化学工业株式会社 记录片材和其生产方法
DE69922962T2 (de) 1998-06-15 2006-01-05 Union Carbide Chemicals & Plastics Technology Corp., Danbury In alkali lösliche verdickungsmittel für latex
FR2785542B1 (fr) * 1998-11-06 2001-02-09 Pf Medicament UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
FR2789588B1 (fr) * 1999-02-17 2001-05-04 Pf Medicament Utilisation d'une proteine ompa d'enterobacterie associee a un antigene dans une composition pharmaceutique destinee a generer ou accroitre une reponse cytotoxique antivirale, antiparasitaire ou antitumorale
FR2789902A1 (fr) 1999-02-24 2000-08-25 Pf Medicament PROTEINE OmpA DE KLEBSIELLA PNEUMONIAE ASSOCIEE A LA CHAINE BETA DE L'HORMONE hCG OU A UN COMPOSE IMPLIQUE DANS LA PROLIFERATION DE CELLULES TUMORALES OU DANS LA FERTILITE, UTILE DANS UNE COMPOSITION PHARMACEUTIQUE
EP1114844A4 (en) 1999-05-28 2005-03-16 Jsr Corp THERMOPLASTIC ELASTOMER EMULSION AND METHOD OF PRODUCING THE SAME

Also Published As

Publication number Publication date
CN1396927A (zh) 2003-02-12
JP2003519238A (ja) 2003-06-17
FR2803302B1 (fr) 2004-12-10
CN1258537C (zh) 2006-06-07
MXPA02006650A (es) 2002-09-30
AU3183701A (en) 2001-07-16
US20030044915A1 (en) 2003-03-06
US7125696B2 (en) 2006-10-24
ATE364622T1 (de) 2007-07-15
WO2001049705A2 (fr) 2001-07-12
CA2397714A1 (fr) 2001-07-12
ZA200204930B (en) 2003-02-06
EP1244690B1 (fr) 2007-06-13
WO2001049705A3 (fr) 2002-02-14
DE60128891D1 (de) 2007-07-26
FR2803302A1 (fr) 2001-07-06
AU783851B2 (en) 2005-12-15
EP1244690A2 (fr) 2002-10-02

Similar Documents

Publication Publication Date Title
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
ATE328068T1 (de) Papillomavirus vakzine
MXPA05009580A (es) Vacuna contra el virus de la influenza.
EA201892671A1 (ru) Пегилированный свиной интерферон и способы его применения
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
CY1115413T1 (el) Ανασυνδυασμενη fsh η οποια περιλαμβανει αλφα 2,3- και αλφα 2',6-sialylation
MY137726A (en) Freeze-dried pantoprazole preparation and pantoprazole injection
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
FR2814958B1 (fr) Composition vaccinale
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
MXPA06013388A (es) Vector lentiviral recombinante para la expresion de una proteina flaviviridae y sus aplicaciones como vacuna.
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
ES2127294T3 (es) Vacunas del virus de la inmunodeficiencia anti-felino (fiv).
DE69230671D1 (de) Impfstoffe gegen actinobacillus pleuropneumonie
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
ATE416788T1 (de) Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
EP0366238A3 (en) Influenza vaccinal polypeptides
BR0112020A (pt) Partìculas tipo vìrus de bvdv
PT964697E (pt) Aplicacoes terapeuticas de antigenios ou epitopos, associados com um processamento celular de peptidos deficiente, e.g. expressos em celulas rma-s transfectadas com um gene b7-1
BR0107421A (pt) Processos de preparação de uma solução purificada de polipeptìdeo solúvel em solvente aquoso e de modulação do sistema imunológico de um mamìfero, polipeptìdeo recombinante, utilização de um polipeptìdeo recombinante, composição terapêutica e vacina
WO2000052045A3 (en) Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof
SE9903534D0 (sv) Vaccin
AR241713A1 (es) Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.